Last reviewed · How we verify

NCT04248660

Uterine Artery Doppler and 11-14 / 20-22 Weeks of Gestation Pregnancy

Completed Last updated 30 January 2020
What this trial tests

trial testing uterine artery doppler measurement in Pregnancy Related in 750 participants. Completed in 1 January 2020.

Timeline
1 January 2016
Primary endpoint
1 January 2020
1 January 2020

Quick facts

Lead sponsorKanuni Sultan Suleyman Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment750
Start date1 January 2016
Primary completion1 January 2020
Estimated completion1 January 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Who can join

Adults 18 to 45, female only, with Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Uterine artery doppler measurements will be made at 11-14 weeks and 20-22 weeks of gestation, and the classification of these measurements according to type of delivery; and to investigate the change in the effect of delivery type on uterine artery flows on obstetric outcomes (maternal, fetal, neonatal outcomes).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pregnancy Related

Currently open trials in the same condition.

Other Kanuni Sultan Suleyman Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04248660.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing